Low-residue breakfast during the preparation for colonoscopy using a polyethylene glycol electrolyte solution: a randomised non-inferiority trial

Jennifer A Flemming, Jordan Green, Andrea Melicharkova, Stephen Vanner, Lawrence Hookey, Jennifer A Flemming, Jordan Green, Andrea Melicharkova, Stephen Vanner, Lawrence Hookey

Abstract

Goals: To test the hypothesis that the use of a low-residue breakfast (LRB) the day prior to colonoscopy was not inferior to consuming clear fluids alone (CFD) in patients undergoing outpatient colonoscopy with a polyethylene glycol (PEG) bowel preparation.

Background: Optimal colon cleansing is essential for complete visualisation of the mucosa during colonoscopy. Few studies have examined the effect of diet on the quality of bowel cleansing or tolerance in patients using a PEG bowel preparation for colonoscopy.

Methods: Randomised, single-blinded non-inferiority trial. Adult patients scheduled for outpatient colonoscopy with PEG solution were randomised to an LRB followed by clear fluids or CFD using either a traditional or split-dose PEG solution for bowel preparation. The primary outcome was colon cleansing based on the Ottawa Bowel Preparation Score (OBPS).

Results: On an intention-to-treat (ITT) basis, a total of 109 and 105 patients were included in the CFD and LRB arms, respectively, with 116 and 98 patients, respectively, for the per-protocol (PP) analysis. Although there was no difference in the mean total OBPS between the CFD or LRB arms in either the ITT or PP analysis, the threshold for non-inferiority was not met. Patient acceptance of the regimens was higher in the LRB arm than in the CFD arm in the ITT and PP analyses.

Conclusions: This study failed to show the non-inferiority of an LRB in patients receiving bowel preparation with a PEG-based solution. A CFD should be prescribed when using a PEG bowel preparation.

Trial registration number: This trial is registered at ClinicalTrials.gov (NCT01454388).

Keywords: CLINICAL DECISION MAKING; COLONOSCOPY; DIET.

Figures

Figure 1
Figure 1
Flow of patients in the study.
Figure 2
Figure 2
Intention-to-treat Aronchick bowel preparation scale results.
Figure 3
Figure 3
Tolerance of the bowel preparation based on randomisation to low-residue breakfast or clear fluid diet CFD.

References

    1. Wolff WI. Colonoscopy: history and development. Am J Gastroenterol 1989;84:1017–25.
    1. Harewood GC, Wiersema MJ, Melton LJ III. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002;97:3186–94.
    1. Abdul-Baki H, Hashash JG, Elhajj II, et al. . A randomized, controlled, double-blind trial of the adjunct use of tegaserod in whole-dose or split-dose polyethylene glycol electrolyte solution for colonoscopy preparation. Gastrointest Endosc 2008;68:294–300.
    1. Flemming JA, Vanner SJ, Hookey LC. Split-dose picosulfate, magnesium oxide, and citric acid solution markedly enhances colon cleansing before colonoscopy: a randomized, controlled trial. Gastrointest Endosc 2012;75:537–44.
    1. Gupta T, Mandot A, Desai D, et al. . Comparison of two schedules (previous evening versus same morning) of bowel preparation for colonoscopy. Endoscopy 2007;39:706–9.
    1. Hookey LC, Vanner S. A review of current issues underlying colon cleansing before colonoscopy. Can J Gastroenterol 2007;21:105–11.
    1. Katz PO, Rex DK, Epstein M, et al. . A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study. Am J Gastroenterol 2013;108:401–9.
    1. Rex DK, Katz PO, Bertiger G, et al. . Split-dose administration of a dual-action, low-volume bowel cleanser for colonoscopy: the SEE CLEAR I study. Gastrointest Endosc 2013;78:132–41.
    1. Siddiqui AA, Yang K, Spechler SJ, et al. . Duration of the interval between the completion of bowel preparation and the start of colonoscopy predicts bowel-preparation quality. Gastrointest Endosc 2009;69:700–6.
    1. Park DI, Park SH, Lee SK, et al. . Efficacy of prepackaged, low residual test meals with 4L polyethylene glycol versus a clear liquid diet with 4L polyethylene glycol bowel preparation: a randomized trial. J Gastroenterol Hepatol 2009;24:988–91.
    1. Rex DK, Johnson DA, Anderson JC, et al. . American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739–50.
    1. Rex DK. Does the use of sedation, or the level of sedation, affect detection during colonoscopy? Am J Gastroenterol 2012;107:1849–51.
    1. Sipe BW, Fischer M, Baluyut AR, et al. . A low-residue diet improved patient satisfaction with split-dose oral sulfate solution without impairing colonic preparation. Gastrointest Endosc 2013;77:932–6.
    1. El Sayed AM, Kanafani ZA, Mourad FH, et al. . A randomized single-blind trial of whole versus split-dose polyethylene glycol-electrolyte solution for colonoscopy preparation. Gastrointest Endosc 2003;58:36–40.
    1. Melicharkova A, Flemming J, Vanner S, et al. . A low-residue breakfast improves patient tolerance without impacting quality of low-volume colon cleansing prior to colonoscopy: a randomized trial. Am J Gastroenterol 2013;108:1551–5.
    1. Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc 2004;59:482–6.
    1. Cardello AV, Schutz HG, Lesher LL, et al. . Development and testing of a labeled magnitude scale of perceived satiety. Appetite 2005;44:1–13.
    1. Aronchick CA, Lipshutz WH, Wright SH, et al. Validation of an instrument to assess colon cleansing [abstract] Am J Gastroenterol 1999;94:2667.
    1. McKnight LC, Day AG, Hookey LC. A formal assessment of the need for teaching prior to the use of the Ottawa Bowel Preparation Scale. Am J Gastroenterol 2006;101:s508.
    1. Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley & Sons, 1987.
    1. Romero RV, Mahadeva S. Factors influencing quality of bowel preparation for colonoscopy. World J Gastrointest Endosc 2013;5:39–46.
    1. Rex DK. Split dosing for bowel preparation. Gastroenterol Hepatol (NY) 2012;8:535–7.
    1. Di PJ, Rex D. Advances in bowel preparations: new formulation and clinical results. Gastroenterol Nurs 2011;34(Suppl 2):S2–8.
    1. Lasisi F, Rex DK. Improving protection against proximal colon cancer by colonoscopy. Expert Rev Gastroenterol Hepatol 2011;5:745–54.
    1. Rex DK, Di Palma JA, Rodriguez R, et al. . A randomized clinical study comparing reduced-volume oral sulfate solution with standard 4-liter sulfate-free electrolyte lavage solution as preparation for colonoscopy. Gastrointest Endosc 2010;72:328–36.
    1. Unger RZ, Amstutz SP, Seo DH, et al. . Willingness to undergo split-dose bowel preparation for colonoscopy and compliance with split-dose instructions. Dig Dis Sci 2010;55:2030–4.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi